Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

197 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Acquired EGFR T790M Mutation After Relapse Following EGFR-TKI Therapy: A Population-based Multi-institutional Study.
Kaburagi T, Kiyoshima M, Nawa T, Ichimura H, Saito T, Hayashihara K, Yamada H, Satoh H, Endo T, Inage Y, Saito K, Inagaki M, Hizawa N, Sato Y, Ishikawa H, Sakai M, Kamiyama K, Kikuchi N, Nakamura H, Furukawa K, Kodama T, Yamashita T, Nomura A, Yoshida S. Kaburagi T, et al. Among authors: nawa t. Anticancer Res. 2018 May;38(5):3145-3150. doi: 10.21873/anticanres.12577. Anticancer Res. 2018. PMID: 29715155
Bevacizumab-containing chemotherapy for non-small cell lung cancer patients: a population-based observational study by the Ibaraki thoracic integrative (POSITIVE) research group.
Nakamura H, Satoh H, Kaburagi T, Nishimura Y, Shinohara Y, Inagaki M, Endo T, Saito T, Hayashihara K, Hizawa N, Kurishima K, Nawa T, Kagohashi K, Kishi K, Ishikawa H, Ichimura H, Hashimoto T, Sato Y, Sakai M, Kamiyama K, Matsumura T, Unoura K, Furukawa K. Nakamura H, et al. Among authors: nawa t. Med Oncol. 2012 Dec;29(5):3202-6. doi: 10.1007/s12032-012-0318-5. Epub 2012 Nov 2. Med Oncol. 2012. PMID: 23117478
Real Clinical Practice in ALK-rearranged NSCLC Patients: A Retrospective Observational Study.
Okauchi S, Numata T, Nawa T, Ichimura H, Saito T, Hayashihara K, Yamada H, Satoh H, Endo T, Inage Y, Kaburagi T, Kiyoshima M, Yamada Y, Tamura T, Saito K, Inagaki M, Hizawa N, Sato Y, Shiozawa T, Sekine I, Ishikawa H, Kurihima K, Sakai M, Kamiyama K, Kimura M, Kikuchi N, Nakamura H, Furukawa K, Kodama T, Miyazaki K, Yamashita T, Hayashi S, Funayama Y, Nomura A. Okauchi S, et al. Among authors: nawa t. Anticancer Res. 2020 Feb;40(2):957-964. doi: 10.21873/anticanres.14029. Anticancer Res. 2020. PMID: 32014940
Observational study on the efficacy and safety of erlotinib in patients with non-small cell lung cancer.
Kaburagi T, Satoh H, Hayashihara K, Endo T, Hizawa N, Kurishima K, Nishimura Y, Hashimoto T, Nakamura H, Kishi K, Inagaki M, Nawa T, Ichimura H, Ishikawa H, Kagohashi K, Fukuoka T, Shinohara Y, Kamiyama K, Sato Y, Sakai M, Matsumura T, Uchiumi K, Furukawa K. Kaburagi T, et al. Among authors: nawa t. Oncol Lett. 2013 Feb;5(2):435-439. doi: 10.3892/ol.2012.1048. Epub 2012 Nov 27. Oncol Lett. 2013. PMID: 23420613 Free PMC article.
Erlotinib for elderly patients with non-small-cell lung cancer: Subset analysis from a population-based observational study by the Ibaraki Thoracic Integrative (POSITIVE) Research Group.
Kurishima K, Satoh H, Kaburagi T, Nishimura Y, Shinohara Y, Inagaki M, Endo T, Saito T, Hayashihara K, Hizawa N, Nakamura H, Nawa T, Kagohashi K, Kishi K, Ishikawa H, Ichimura H, Hashimoto T, Sato Y, Sakai M, Kamiyama K, Matsumura T, Unoura K, Fukuoka T, Uchiumi K, Nomura A, Furukawa K. Kurishima K, et al. Among authors: nawa t. Mol Clin Oncol. 2013 Sep;1(5):828-832. doi: 10.3892/mco.2013.154. Epub 2013 Jul 23. Mol Clin Oncol. 2013. PMID: 24649255 Free PMC article.
Efficacy of first-line erlotinib in non-small cell lung cancer patients undergoing dose reduction and those with a low body surface area: A population-based observational study by the Ibaraki Thoracic Integrative (POSITIVE) Research Group.
Inagaki M, Shinohara Y, Kaburagi T, Homma S, Hizawa N, Nakamura H, Hayashihara K, Saito T, Ishikawa H, Ichimura H, Nawa T, Kikuchi N, Miyazaki K, Kodama T, Kamiyama K, Satoh H, Furukawa K. Inagaki M, et al. Among authors: nawa t. Mol Clin Oncol. 2016 Mar;4(3):425-428. doi: 10.3892/mco.2015.720. Epub 2015 Dec 21. Mol Clin Oncol. 2016. PMID: 26998297 Free PMC article.
S-1-containing chemotherapy for patients with non-small-cell lung cancer: A population-based observational study by the Ibaraki thoracic integrative (POSITIVE) research group.
Inagaki M, Shinohara Y, Kaburagi T, Endo T, Homma S, Hizawa N, Kishi K, Nakamura H, Hayashihara K, Saito T, Kurishima K, Ishikawa H, Ichimura H, Nawa T, Kikuchi N, Miyazaki K, Kodama T, Satoh H, Furukawa K. Inagaki M, et al. Among authors: nawa t. Mol Clin Oncol. 2016 Jun;4(6):1025-1030. doi: 10.3892/mco.2016.826. Epub 2016 Mar 21. Mol Clin Oncol. 2016. PMID: 27284438 Free PMC article.
A population-based study of gefitinib in patients with non-small cell lung cancer.
Hayashibara K, Satoh H, Shinohara Y, Inagaki M, Kaburagi T, Hashimoto T, Kurishima K, Ishikawa H, Ichimura H, Nawa T, Funayama Y, Matsumura T, Kagohashi K, Endo T, Furukawa K, Kishi K, Sumi M, Kamiyama K, Ishikawa S. Hayashibara K, et al. Among authors: nawa t. Med Oncol. 2009;26(2):222-7. doi: 10.1007/s12032-008-9110-y. Epub 2008 Oct 31. Med Oncol. 2009. PMID: 18975151
197 results